This company produces biocompatible artificial spider silk using bacteria for medical applications. The resulting material offers high strength, elasticity, and biodegradability, enabling new approaches to tissue regeneration and reconstructive surgery.
Funding
Funding not disclosed
Founders
Product
Problem
Current synthetic materials used in medical applications often lack the strength, flexibility, biocompatibility, and biodegradability necessary for optimal tissue regeneration and long-term integration within the human body. Traditional manufacturing processes for these materials can also be environmentally unsustainable, relying on harsh solvents and non-renewable resources.
Solution
PrintyMed produces biomimetic spider silk using a bacteria-based production process for a range of medical and cosmetic applications. The resulting material exhibits exceptional strength, flexibility, and biocompatibility, promoting cell adhesion and integration into human tissues. PrintyMed's proprietary technology replicates the natural spinning process of spider silk through advanced protein engineering and scalable production methods. Their sustainable, non-animal-based process uses water as the sole solvent, minimizing environmental impact while delivering high-performance biomaterials.
Target Audience
PrintyMed serves the medical device, regenerative medicine, and cosmetic industries, including researchers, clinicians, and manufacturers seeking advanced biomaterials with enhanced performance and sustainability.
Features
- Biomimetic spider silk with twice the strength of other artificial spider silks
- High flexibility, exhibiting nearly double the extensibility in high-humidity conditions compared to natural flagelliform silk
- Customizable properties, allowing silk fibers to be tailored to specific applications
- Non-animal-based production in bacteria
- Biocompatibility that facilitates cell adhesion, regeneration, and integration into human tissues
- Sustainable and eco-friendly process using water as the sole solvent
- Organs-on-a-chip membranes for drug screening and disease modeling
- Biomimetic spider silk proteins for regenerative properties in high-end cosmetics
- Durable and biocompatible heart valve prostheses
- Advanced wound dressings that promote cell regeneration and reduce infection risks
- Artificial organs and scaffolds for biocompatible, patient-specific solutions